Allerderm: Clinical Trials

11 trials sponsored by Allerderm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 unknown, 1 withdrawn. 5 Phase 2, 3 Phase 3, 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 33Completed 1, Unknown 1, Withdrawn 1
Phase 42Completed 2
Not applicable1Completed 1

Follow Allerderm: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metal Panel Allergen Patch Test Study
Metal Panel T.R.U.E. Test - Atopic Dermatitis Eczema
Phase 3UnknownAllerderm2002022-02-072023-02-13
Clinical Evaluation of Metal Panel Allergens: Dose Response Study
Metal Allergen Epicutaneous Patch - Dermatitis, Eczematous
Phase 2CompletedAllerderm1222016-12-052020-08-25
Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
Ammoniated mercury, Aluminum chloride and aluminum lactate, Sodium tetrachloropalladate - Contact Dermatitis
Phase 2CompletedAllerderm562013-11-042020-08-24
Clinical Evaluation of Lyral® Dose Response Study
Lyral® - Contact Dermatitis
Phase 2CompletedAllerderm222013-02-012023-07-28
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Panels 1.3, 2.2 and 3.2 experimental allergens - Allergic Contact Dermatitis
Not applicableCompletedAllerderm1162012-12-102020-08-21
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
Patch Test - Contact Dermatitis
Phase 3WithdrawnAllerderm2012-12-012013-02-27
Bioequivalence of Ethylenediamine Dihydrochloride Study
Ethylenediamine dihydrochloride allergen patch - Allergic Contact Dermatitis
Phase 4CompletedAllerderm162012-07-012023-07-28
Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents
T.R.U.E. Test - Dermatitis, Contact
Phase 4CompletedAllerderm1022008-11-012020-08-06
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens - Contact Dermatitis
Phase 2CompletedAllerderm482008-04-012018-04-09
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens - Contact Dermatitis
Phase 3CompletedAllerderm2352008-04-012020-05-05
Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations
TRUE Test allergens Fragrance Mix and Thimerosol - Dermatitis, Contact
Phase 2CompletedAllerderm502008-01-012018-04-09

Conditions studied

Dermatitis, Contact (8)  ·  Dermatitis, Allergic Contact (3)  ·  Eczema (2)  ·  Dermatitis (1)  ·  Hypersensitivity (1)

Interventions

Patch Tests (1)  ·  Thimerosal (1)  ·  hydroxyisohexyl 3-cyclohexene carboxaldehyde (1)

Countries

United States (9)  ·  Denmark (3)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Joseph Fowler, MD (6)  ·  Cory Dunnick, MD (2)  ·  Evy Paulsen, M.D., Ph.D (2)  ·  Jerri Hoskyn, MD (2)  ·  Lawrence Eichenfield, MD (2)  ·  Luz Fonacier, MD (2)  ·  Akiko Yagami, MD, PhD (1)  ·  Andreas Bircher, MD (1)  ·  Curt Hamann, M.D. (1)  ·  Donald V Belsito, MD (1)  ·  Donald V. Belsito, MD (1)  ·  Evy Paulsen, Md, PhD (1)  ·  Karin Pacheco, MD (1)  ·  Maki Hosoki, DDS, PhD (1)  ·  Marlene Isaksson, MD (1)

NIH funding

2008 (1)